Abstract
The aim of this study was to verify the presence of presynaptic nicotinic acetylcholine receptors (nAChRs) at the terminals of myenteric motoneurons using a potent and highly selective nicotinic agonist, epibatidine. We examined contraction, and release of [3H]ACh on a guinea-pig longitudinal muscle strip preparation. First, we compared the ability of epibatidine and nicotine to induce isometric contraction and found epibatidine (EC50 = 23.1 nM) to be 300-fold more potent than nicotine (EC50 = 7.09 μM). The release and contraction induced by 30 nM epibatidine were inhibited by the nicotinic antagonist mecamylamine (3 μM) and the Na1-channel blocker TTX (1 μM), indicating that the effects are mediated via nAChRs and are fully dependent on the propagation of action potentials. Atropine (0.1 μM) significantly increased the [3H]ACh release but could not block contraction suggesting that a substantial part of the response develops via a noncholinergic mechanism. Epibatidine at a higher concentration (300 nM) induced contraction, which was only partly (45%) inhibited by TTX (1 μM). The TTX-resistant contraction, however, was completely blocked by mecamylamine (3 μM). Our data provide functional neurochemical evidence for the existence of presynaptic nAChRs at myenteric motoneuron terminals and suggest that these receptors can be activated only/by a higher concentration of agonists.
Similar content being viewed by others
REFERENCES
Torocsik, A., Oberfrank, F., Sershen, H., Lajtha, A., Nemesy, K., and Vizi, E. S. 1991. Characterization of somatodendritic neuronal nicotinic receptors located on the myenteric plexus. Eur. J. Pharmacol. 202:297–302.
Vizi, E. S., Sershen, H., Balla, A., Mike, A., Windisch, K., Juranyi, Z., and Lajtha, A. 1995. Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nicotinic acetylcholine receptors. Ann. N. Y. Acad. Sci. 757:84–99.
Galligan, J. J. 1999. Nerve terminal nicotinic cholinergic receptors on excitatory motoneurons in the myenteric plexus of guinea pig intestine. J. Pharmacol. Exp. Ther. 291:92–98.
Ehlert, F. J., Sawyer, G. W., and Esqueda, E. E. 1999. Contractile role of M2 and M3 muscarinic receptors in gastrointestinal smooth muscle. Life Sci. 64:387–394.
Vizi, E. S. 1979. Presynaptic modulation of neurochemical transmission. Prog. Neurobiol. 12:181–290.
Paton, W. D. and Vizi, E. S. 1969. The inhibitory action of nor-adrenaline and adrenaline on acetylcholine output by guinea pig ileum longitudinal muscle strip. Br. J. Pharmacol. 35:10–28.
Paton, W. D., Vizi, E. S., and Zar, M. A. 1971. The mechanism of acetylcholine release from parasympathetic nerves. J. Physiol. 215:819–848.
Schneider, D. A., Perrone, M., and Galligan, J. J. 2000. Nicotinic acetylcholine receptors at sites of neurotransmitter release to the guinea pig intestinal circular muscle. J. Pharmacol. Exp. Ther. 294:363–369.
Niebler, M. and Trendelenburg, U. 1990. Mechanisms of the release of 3H-noradrenaline by dimethylphenylpiperazinium (DMPP) in the rat vas deferens. Naunyn Schmiedebergs Arch. Pharmacol. 341:43–49.
Kiss, J. P., Windisch, K., Balla, A., Sershen, H., and Lajtha, A. 1997. Dual effect of DMPP on the resting release of nor-adrenaline from rat hippocampal slices. Brain Res. Bull. 43: 257–262.
Kiss, J. P., Windisch, K., De Oliveira, K., Hennings, E. C., Mike, A., and Szasz, B. K. 2001. Differential effect of nicotinic agonists on the [3H]norepinephrine release from rat hippocampal slices. Neurochem. Res. 26:943–950.
Arqueros, L., Naquira, D., and Zunino, E. 1978. Nicotine-induced release of catecholamines from rat hippocampus and striatum. Biochem. Pharmacol. 27:2667–2674.
Bonhaus, D. W., Bley, K. R., Broka, C. A., Fontana, D. J., Leung, E., Lewis, R., Shieh, A., and Wong, E. H. 1995. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine. J. Pharmacol. Exp. Ther. 272: 1199–1203.
Gerzanich, V., Peng, X., Wang, F., Wells, G., Anand, R., Fletcher, S., and Lindstrom, J. 1995. Comparative pharmacology of epibatidine: A potent agonist for neuronal nicotinic acetylcholine receptors. Mol. Pharmacol. 48:774–782.
Lembeck, F. 1999. Epibatidine: High potency and broad spectrum activity on neuronal and neuromuscular nicotinic acetylcholine receptors. Naunyn Schmiedebergs Arch. Pharmacol. 359:378–385.
Kirchgessner, A. L. and Liu, M. T. 1998. Immunohistochemical localization of nicotinic acetylcholine receptors in the guinea pig bowel and pancreas. J. Comp. Neurol. 390:497–514.
Spande, T. F., Garraffo, H. M., Yeh, H. J., Pu, Q. L., Pannell, L. K., and Daly, J. W. 1992. A new class of alkaloids from a dendrobatid poison frog: A structure for alkaloid 251F. J. Nat. Prod. 55:707–722.
Bannon, A. W., Decker, M. W., Holladay, M. W., Curzon, P., Donnelly-Roberts, D., Puttfarcken, P. S., Bitner, R. S., Diaz, A., Dickenson, A. H., Porsolt, R. D., Williams, M., and Arneric, S. P. 1998. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science 279:77–81.
Donnelly-Roberts, D. L., Puttfarcken, P. S., Kuntzweiler, T. A., Briggs, C. A., Anderson, D. J., Campbell, J. E., Piattoni-Kaplan, M., McKenna, D. G., Wasicak, J. T., Holladay, M. W., Williams, M., and Arneric, S. P. 1998. ABT-594 [(R)-5-(2-azetidinyl-methoxy)-2-chloropyridine]: A novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization. J. Pharmacol. Exp. Ther. 285:777–786.
Qian, C., Li, T., Shen, T. Y., Libertine-Garahan, L., Eckman, J., Biftu, T., and Ip, S. 1993. Epibatidine is a nicotinic analgesic. Eur. J. Pharmacol. 250:R13–R14.
Alkondon, M. and Albuquerque, E. X. 1995. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. J. Pharmacol. Exp. Ther. 274:771–782.
Kadlec, O., Seferna, I., Sevcik, J., Somogyi, G. T., and Vizi, E. S. 1990. The topographical basis of cholinergic transmission in guinea pig ileum myenteric plexus. Neuroscience 36:793–802.
Somogyi, G. T. and Vizi, E. S. 1988. Evidence that cholinergic axon terminals are equipped with both muscarinic and adenosine receptors. Brain Res. Bull. 21:575–579.
Wonnacott, S. 1997. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:92–98.
Vizi, E. S. and Lendvai, B. 1999. Modulatory role of presynap-tic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system. Brain Res. Brain Res. Rev. 30:219–235.
Vizi, E. S. 2000. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. Pharmacol. Rev. 52:63–90.
Coulie, B., Camilleri, M., Bharucha, A. E., Sandborn, W. J., and Burton, D. 2001. Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects. Aliment Pharmacol. Ther. 15: 653–663.
Green, J. T., McKirdy, H. C., Rhodes, J., Thomas, G. A., and Evans, B. K. 1999. Intra-luminal nicotine reduces smooth muscle tone and contractile activity in the distal large bowel. Eur. J. Gastroenterol. Hepatol. 11:1299–1304.
Meier, R., Beglinger, C., Dederding, J. P., Meyer-Wyss, B., Fumagalli, M., Rowedder, A., Turberg, Y., and Brignoli, R. 1995. Influence of age, gender, hormonal status and smoking habits on colonic transit time. Neurogastroenterol. Motil. 7:235–238.
Rausch, T., Beglinger, C., Alam, N., Gyr, K., and Meier, R. 1998. Effect of transdermal application of nicotine on colonic transit in healthy nonsmoking volunteers. Neurogastroenterol. Motil. 10:263–270.
Somogyi, G. T., Zernova G. V., Yoshiyama, M., Rocha, J. N., Smith C. P., and Groat, W. C. 2003. Change in muscarinic modulation of transmitter release in the rat urinary bladder after spinal cord injury. Neurochem. Int. In press.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mandl, P., Kiss, J.P. & Vizi, E.S. Functional Neurochemical Evidence for the Presence of Presynaptic Nicotinic Acetylcholine Receptors at the Terminal Region of Myenteric Motoneurons: A Study with Epibatidine. Neurochem Res 28, 407–412 (2003). https://doi.org/10.1023/A:1022884231313
Issue Date:
DOI: https://doi.org/10.1023/A:1022884231313